학술논문
499P Long-term survival and treatment (tx) patterns after first-line (1L) osimertinib in patients (pts) with epidermal growth factor receptor (EGFR) mutation-positive (m) advanced non-small cell lung cancer (NSCLC): Japanese cohort of a global real-world (rw) observational study
Document Type
Article
Author
Source
Subject
*EPIDERMAL growth factor receptors
*NON-small-cell lung carcinoma
*OSIMERTINIB
*
*
Language
ISSN
0923-7534